Market Tracker

11/21 6:05pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

110.51
Data as of Nov 21
 -0.11 / -0.10%
Today’s Change
85.21
Today|||52-Week Range
113.53
+25.62%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Performance

1 month+7.17% 3 years+32.92%
3 months+11.20% 5 years+26.77%
1 year+28.53% Since inception+17.48%
Data through 11/15/2014

Quote Details

Previous close$110.62
Open day’s range110.42 – 111.79
Net asset value (NAV)108.50 (11/14/2014)
Daily volume71,086
Average volume (3 months)70,387
Data as of 3:58pm ET, 11/21/2014

Peer Comparisonvs. Health ETFs

 XPHCategory
Performance 5-yr return+26.77%+21.83%
Expense Gross exp ratio0.35%0.44%
Risk 5 year sharpe ratio1.771.54
Net assets$1.0B$1.5B
Average market cap$8.0B$31.2B
Average P/E33.828.5
Dividend / Share--0.20%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
LCI Lannett Co Inc4.43%
AUXL Auxilium Pharmaceuticals Inc4.42%
AVNR AVANIR Pharmaceuticals Class A4.01%
IPXL Impax Laboratories Inc3.71%
AKRX Akorn Inc3.69%
BMY Bristol-Myers Squibb Company3.57%
MYL Mylan Inc3.51%
AGN Allergan Inc3.47%
PRGO Perrigo Co PLC3.45%
ABBV AbbVie Inc3.38%